ABSTRACT
OBJECTIVE: By analyzing cases of medical disputes occurred in one of top hospitals in Shanghai from 2012 to 2014, the paper tries to determine the causes and cures of the disputes based on relevant national and international experience. METHODS: A cluster sample of medical disputes occurred in the hospital from 2012 to 2014 was selected, to which logistic regression analysis was applied in order to determine the factors causing medical disputes. RESULTS: Inadequate experience in dealing with unexpected incidents (P = 0.002), violation of routine procedures for diagnosis and treatment (P = 0.004), and therapeutic effects (P = 0.007) were found to be statistically significant. CONCLUSION: Medical disputes in the hospital would be substantially reduced by taking such measures as strengthening trainings on how to deal with unexpected incidents for medical staff, standardizing procedures for clinical practices, and improving the therapeutic effects of various diseases.
Subject(s)
Dissent and Disputes , Hospitals, Urban/statistics & numerical data , China , Compensation and Redress , Dissent and Disputes/economics , Humans , Logistic Models , Patients/statistics & numerical data , Physician-Patient Relations , Physicians/statistics & numerical data , Retrospective Studies , Risk Factors , Surveys and QuestionnairesSubject(s)
Civil Disorders , Delivery of Health Care , Dissent and Disputes , Health Services Accessibility , Humans , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/virology , COVID-19 Vaccines/supply & distribution , Delivery of Health Care/economics , Delivery of Health Care/statistics & numerical data , Democracy , Dissent and Disputes/economics , Health Occupations/statistics & numerical data , Health Services Accessibility/statistics & numerical data , Human Rights Abuses , Incidence , Malaria/epidemiology , Myanmar , PoliticsABSTRACT
We examine a recent dispute regarding the Centers for Medicare and Medicaid Services' (CMS) refusal to unconditionally pay for amyloid positron emission tomography (PET) imaging for Medicare beneficiaries being assessed for Alzheimer's disease. CMS will only pay for amyloid PET imaging when patients are enrolled in clinical trials that meet certain criteria. The dispute reflects CMS's willingness in certain circumstances to require effectiveness evidence that differs from the Food and Drug Administration's standard for pre-market approval of a medical intervention and reveals how stakeholders with differing perspectives about evidentiary standards have played a role in attempting to shape the Medicare program's coverage policies.
Subject(s)
Dissent and Disputes/economics , Insurance Coverage/economics , Medicare/economics , Positron-Emission Tomography/economics , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/economics , Centers for Medicare and Medicaid Services, U.S./economics , Clinical Trials as Topic , Evidence-Based Medicine , Humans , United StatesABSTRACT
Events involving applications for compensation or filing a complaint in a MRSA case in Finland by patients or family members were studied for over a twenty-year period. The number of cases found was 305. Of the applications, only 7% resulted in compensation, and none of the complaints led to a change in decision. The discontentment was more commonly associated with the possible MRSA-induced impairment of the given treatment or limitations in freedom than with the fear of the direct health effects of the infection. In order to avoid problems, essential aspects include an intimate knowledge of guidelines among those working in the treatment and care sector, and proper informing of the patients about the effects of MRA on life.
Subject(s)
Compensation and Redress , Dissent and Disputes/economics , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/epidemiology , Staphylococcal Infections/therapy , Finland/epidemiology , HumansABSTRACT
Read the story of one group's efforts to recoup money owed from unpaid claims with a systematic approach. The partnership of emergency physicians, urgent care physicians and hospitalists recoups about $4 million annually from these efforts.
Subject(s)
Dissent and Disputes/economics , Insurance Claim Review/standards , Insurance, Health, Reimbursement/economics , Humans , Insurance Claim Review/economics , Insurance Claim Review/statistics & numerical data , Insurance, Health, Reimbursement/standards , Insurance, Health, Reimbursement/statistics & numerical dataSubject(s)
Dissent and Disputes/history , Federal Government , National Health Programs/history , Physicians/history , Salaries and Fringe Benefits/history , State Government , Canada , Dissent and Disputes/economics , Dissent and Disputes/legislation & jurisprudence , History, 20th Century , Humans , National Health Programs/economics , National Health Programs/legislation & jurisprudence , Physicians/economics , Physicians/legislation & jurisprudence , Salaries and Fringe Benefits/economics , Salaries and Fringe Benefits/legislation & jurisprudence , SaskatchewanSubject(s)
Ambulatory Care Facilities/legislation & jurisprudence , Centers for Medicare and Medicaid Services, U.S./legislation & jurisprudence , Dissent and Disputes/legislation & jurisprudence , Patient Safety/legislation & jurisprudence , Ambulatory Care Facilities/economics , Ambulatory Care Facilities/standards , Centers for Medicare and Medicaid Services, U.S./economics , Disclosure/legislation & jurisprudence , Dissent and Disputes/economics , Humans , Ohio , Patient Safety/economics , Patient Safety/standards , Reimbursement Mechanisms/economics , Reimbursement Mechanisms/legislation & jurisprudence , United StatesABSTRACT
BACKGROUND: Prior studies on the impact of problem gambling in the family mainly include help-seeking populations with small numbers of participants. The objective of the present stratified probability sample study was to explore the epidemiology of problem gambling in the family in the general population. METHODS: Men and women 16-74 years-old randomly selected from the Norwegian national population database received an invitation to participate in this postal questionnaire study. The response rate was 36.1% (3,483/9,638). Given the lack of validated criteria, two survey questions ("Have you ever noticed that a close relative spent more and more money on gambling?" and "Have you ever experienced that a close relative lied to you about how much he/she gambles?") were extrapolated from the Lie/Bet Screen for pathological gambling. Respondents answering "yes" to both questions were defined as Concerned Significant Others (CSOs). RESULTS: Overall, 2.0% of the study population was defined as CSOs. Young age, female gender, and divorced marital status were factors positively associated with being a CSO. CSOs often reported to have experienced conflicts in the family related to gambling, worsening of the family's financial situation, and impaired mental and physical health. CONCLUSION: Problematic gambling behaviour not only affects the gambling individual but also has a strong impact on the quality of life of family members.
Subject(s)
Behavior, Addictive/epidemiology , Dissent and Disputes/economics , Family Health , Family/psychology , Gambling/psychology , Health Surveys , Adolescent , Adult , Aged , Behavior, Addictive/complications , Behavior, Addictive/economics , Behavior, Addictive/psychology , Child , Conflict, Psychological , Female , Humans , Male , Middle Aged , Norway/epidemiology , Prevalence , Risk Factors , Risk-Taking , Sampling Studies , Stress, Psychological/economics , Stress, Psychological/etiology , Surveys and Questionnaires , Young AdultSubject(s)
Health Insurance Exchanges/legislation & jurisprudence , Hospitals, Pediatric/legislation & jurisprudence , Insurance Coverage/legislation & jurisprudence , Dissent and Disputes/economics , Dissent and Disputes/legislation & jurisprudence , Health Insurance Exchanges/economics , Hospitals, Pediatric/economics , Humans , Insurance Coverage/economics , United States , WashingtonSubject(s)
Financing, Government/legislation & jurisprudence , Health Facilities/economics , Medicare Part C/economics , Reimbursement Mechanisms/economics , Budgets/legislation & jurisprudence , Contract Services/economics , Contract Services/legislation & jurisprudence , Cost Control/legislation & jurisprudence , Dissent and Disputes/economics , Dissent and Disputes/legislation & jurisprudence , Financing, Government/trends , Health Facilities/legislation & jurisprudence , Humans , Medicare Part C/legislation & jurisprudence , Politics , Reimbursement Mechanisms/legislation & jurisprudence , Reimbursement Mechanisms/trends , United StatesABSTRACT
This article is the second part of a trilogy that discusses IP issues related to anti-Tumor Necrosis factor α (TNFα) biologics. TNFα is the world's most valuable target, with accumulated sales of TNFα biologics of 34 bn USD in 2014. While in the first part of this trilogy, Humira was discussed, this second parts discusses the patent strategies of Enbrel, Remicade, Cimzia and Simponi.
Subject(s)
Adalimumab/economics , Antirheumatic Agents/economics , Arthritis, Rheumatoid/drug therapy , Biosimilar Pharmaceuticals/economics , Dissent and Disputes/economics , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adalimumab/therapeutic use , Antibodies, Monoclonal/economics , Antibodies, Monoclonal/therapeutic use , Antirheumatic Agents/supply & distribution , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/economics , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Biosimilar Pharmaceuticals/supply & distribution , Biosimilar Pharmaceuticals/therapeutic use , Certolizumab Pegol/economics , Certolizumab Pegol/therapeutic use , Dissent and Disputes/legislation & jurisprudence , Drug Administration Schedule , Drug Dosage Calculations , Etanercept/economics , Etanercept/therapeutic use , Gene Expression Regulation , Humans , Infliximab/economics , Infliximab/therapeutic use , Patents as Topic , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunologyABSTRACT
OBJECTIVE: In Taiwan, the number of medical disputes and litigation has increased dramatically over the past 20 years. The seriousness of medical disputes continuing grows in clinical practice, especially in obstetricians. This study provided a possible solution to the medical dispute litigation issue. MATERIALS AND METHODS: The Ministry of Health and Welfare (MOHW) compensation program for birth incidents has been implemented since 2012 and it provided pecuniary compensation for mothers, newborns, and fetuses who got injured or died in birth-related medical incidents. We analyzed the amount and distribution of compensation, and assessed the effect of compensation on the number of medical dispute litigation. RESULTS: From 2012 to 2015, a total of 348 applications was received, 322 of which were examined by the committee. Among the examined cases, 278 were approved for compensation. The total amount of compensation had reached 266.16 million NTD (8.32 million USD). For the medical dispute litigation, a dramatic decrease in number was observed after the implementation of this compensation pilot program. CONCLUSION: Prompt compensation provided instant economic and spiritual support for patients and families. Pecuniary compensation could be an alternative choice of justice, which might encourage the injured to receive economic compensation, instead of filing a lawsuit against the physician or hospital institution. As a result, the number of dispute litigation has decreased. This indicates that the compensation program is an efficient way to improve medical dispute litigation difficulties.
Subject(s)
Compensation and Redress/legislation & jurisprudence , Dissent and Disputes/legislation & jurisprudence , Malpractice/legislation & jurisprudence , Obstetrics/legislation & jurisprudence , Birth Injuries/epidemiology , Dissent and Disputes/economics , Female , Humans , Infant, Newborn , Malpractice/statistics & numerical data , Obstetrics/economics , Obstetrics/trends , Pilot Projects , Pregnancy , Pregnancy Outcome/epidemiology , Taiwan/epidemiologySubject(s)
Centers for Medicare and Medicaid Services, U.S./legislation & jurisprudence , Dissent and Disputes/legislation & jurisprudence , Insurance, Health/legislation & jurisprudence , Patient Protection and Affordable Care Act , Centers for Medicare and Medicaid Services, U.S./economics , Dissent and Disputes/economics , Humans , Insurance, Health/economics , United StatesSubject(s)
Health Personnel/legislation & jurisprudence , Health Services Accessibility/legislation & jurisprudence , Medicaid/legislation & jurisprudence , Dissent and Disputes/economics , Dissent and Disputes/legislation & jurisprudence , Government Regulation , Health Personnel/economics , Humans , Medicaid/economics , United StatesSubject(s)
Health Care Sector/economics , Health Care Sector/trends , National Health Programs/economics , National Health Programs/trends , Organizational Objectives , Politics , Societies, Medical/trends , Attitude of Health Personnel , Cost Savings/trends , Dissent and Disputes/economics , Education, Medical/economics , Education, Medical/trends , Forecasting , Germany , Healthcare Disparities/economics , Healthcare Disparities/trends , Humans , Professional Autonomy , Resource Allocation/economics , Resource Allocation/trends , Social ConformityABSTRACT
Economic inequality is at historically high levels in the United States and is among the most pressing issues facing society. And yet, predicting the behavior of politicians with respect to their support of economic inequality remains a significant challenge. Given that high status individuals tend to conceive of the current structure of society as fair and just, we expected that high status members of the U.S. House of Representatives would be more likely to support economic inequality in their legislative behavior than would their low status counterparts. Results supported this prediction particularly among Democratic members of Congress: Whereas Republicans tended to support legislation increasing economic inequality regardless of their social status, the social status of Democrats - measured in terms of average wealth, race, or gender - was a significant predictor of support for economic inequality. Policy implications of the observed relationship between social status and support for economic inequality are considered.